Volume 38; Issue 3-supp-S1

Main
Bone
Volume 38; Issue 3-supp-S1

Bone

Volume 38; Issue 3-supp-S1

1

Alterations in canine vertebral bone turnover, mineralization, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate

M.R. Allen, K. Iwata, R. Phipps ⁎, D.B. Burr

Journal:

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

2

Microcrack initiation occurs more easily in vertebrae from beagles treated with alendronate than with risedronate

K. Iwata, M.R. Allen, R. Phipps *, D.B. Burr

Journal:

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

3

Optimal timing of bolus intravenous zoledronic acid in a rat fracture model

N. Amanat, M. McDonald, C. Godfrey, L. Bilston, D. Little

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

4

Zoledronic acid and PTH increase bone mass and mechanical strength following radiation therapy for osteolytic bone metastases

S.A. Arrington, J.E. Schoonmaker, K.A. Mann, T.A. Damron, T. Sledz, G. Willick, M.J. Allen

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

5

Effects of ibandronate and zoledronic acid in a model of inflammatory pain

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

6

Understanding the binding mechanism of substrates and bisphosphonates with farnesyl pyrophosphate synthase—A microcalorimetry study

F. Bitsch, P. Lefeuvre, D. Bègue, E. Bourgier, W. Jahnke, J.-M. Rondeau

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

7

New strategies based on zoledronic acid/tipifarnib combination in the therapy of prostate cancer

M. Caraglia ⁎, M. Marra, C. Leonetti, G. Meo, F. Bruzzese, S. Addeo, G. Zupi, A. Abbruzzese, A. Budillon

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

8

Continuous or repeated intermittent low-dose therapy with zoledronic acid induces a sustained inhibition of tumor cell trafficking to bone in vivo

J. Guglielmi, F. Daubiné, J. Gasser ⁎, J. Green ⁎, P. Clézardin

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

9

The direct antitumor activity of bisphosphonates in vivo depends on their bone mineral affinity

P. Fournier, F. Daubiné, M.W. Lundy ⁎, F.H. Ebetino ⁎, P. Clézardin

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

10

Inhibition of post-translational prenylation causes sustained activation of RAC, Cdc42 and Rho GTPases

Fraser P. Coxon, James E. Dunford, Michael J. Rogers

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

11

Resorbing osteoclasts increase the availability of mineral-bound bisphosphonates to non-resorbing cells

Fraser P. Coxon, Keith Thompson, F. Hal Ebetino ⁎, Michael J. Rogers

Journal:

Year:

2006

Language:

english

File:

PDF, 59 KB

english, 2006

12

Structure-activity relationships of bisphosphonate analogues

F.P. Coxon, J. Rojas Navea, C.A. Stewart, J. Al Jaber, F.H. Ebetino ⁎, C.E. McKenna #, B.A. Kashemirov #, I. Mallard #, M.J. Rogers

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

13

Target enzyme specificity, potency and potential lack of side-effects of novel phosphonocarboxylate analogues of bisphosphonates

F.P. Coxon, J. Rojas Navea, C.A. Stewart, K. Thompson, A. Roelofs, F.H. Ebetino ⁎, C.E. McKenna #, B.A. Kashemirov #, J. Bala #, M.J. Rogers

Journal:

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

14

Cytosolic entry of Bisphosphonates into macrophages and osteoclasts requires fluid-phase endocytosis and endosomal acidification

Keith Thompson, Michael J. Rogers, Fraser P. Coxon, Julie C. Crockett

Journal:

Year:

2006

Language:

english

File:

PDF, 56 KB

english, 2006

15

Investigations into the kinetic mechanism of inhibition of farnesyl diphosphate synthase by nitrogen containing bisphosphonates

J.E. Dunford, K. Kavanagh, U. Oppermann, F.H. Ebetino, R.G.G. Russell, M.J. Rogers

Journal:

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

16

Ibandronate improves osseointegration of cementless metal implants to a similar extent either given continuously or as a single equivalent dose

C. Eberhardt, M. Schwarz, J. Brahnkamp, F. Bauss, A.A. Kurth

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

17

Improvement of Osseointegration of Cementless Metal Implant under Ibandronate is dose-dependent

C. Eberhardt, B. Habermann, S. Tiemann, F. Bauss, A.A. Kurth

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

18

A computational model explains bisphosphonate binding affinity differences on hydroxyapatite

F.H. Ebetino, B.L. Barnett, R.G.G. Russell, Z. Henneman, G.H. Nancollas

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

19

Human farnesyl diphosphate synthase crystal structures with active and inactive bisphosphonates

A. Evdokimov, M. Pokross, B.L. Barnett, K. Kavanagh, U. Oppermann, R.G.G. Russell, C.E. McKenna, F.H. Ebetino

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

20

Molecular modeling comparison of nitrogen-containing bisphosphonates of varying potency co-crystalized in farnesyl diphosphate synthase

F.H. Ebetino, B. Kashemirov, C.E. McKenna, A. Evdokimov, M. Pokross, B.L. Barnett, J. Dunford, K. Kavanagh, M.J. Rogers, M.W. Lundy, U. Oppermann, R.G.G. Russell

Journal:

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

21

Trabecular bone turnover is reestablished sooner in ovariectomized rats after withdrawal of treatment with risedronate vs alendronate

R.K. Fuchs, R.J. Phipps, D.B. Burr

Journal:

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

22

Inhibition of FPP-synthase in osteoblasts may explain the blunting of the bone anabolic response to PTH observed after chronic exposure of rats to bisphosphonates

J.A. Gasser, P. Ingold, A. Rebmann, M. Susa, J.R. Green

Journal:

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

23

Anti-nociceptive effects of the bisphosphonate risedronate in a syngeneic mouse model of bone cancer pain

A. Hald, R.R. Hansen, M. Wisbom Sorensen, M. Ding, M. Kassem, F.H. Ebetino, A.M. Heegaard

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

24

Zoledronic acid slows down rat primary chondrosarcoma development, recurrente tumor progression after intralesional curretage and increases overall survival

F. Gouin, F. Rédini, B. Ory, D. Heymann

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

25

Effects of zoledronic acid on apoptosis in tumour cell lines; repeated low dosing compared to continuous treatment

I. Holen, R. Patel, D.V. Lefley, H.L. Neville Webbe, R.E. Coleman, J.K.L. Woodward

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

26

Nitrogen-containing bisphosphonates may exert potent estrogenic effects on MCF-7 breast cancer cells growth

F. Journé, C. Chaboteaux, G. Leclercq #, G. Laurent ⁎, J.J. Body

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

27

Sequence-dependent synergistic effects of ibandronate in combination with antiestrogens on growth inhibition of estrogen receptor-positive breast cancer cells

F. Journé, C. Chaboteaux, G. Laurent ⁎, J.J. Body

Journal:

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

28

Crystal structures and molecular interactions of risedronate and zoledronate with human farnesyl diphosphate synthase

K.L. Kavanagh, K. Guo, X. Wu, S. Knapp, F.H. Ebetino, J.E. Dunford, M.J. Rogers, R.G.G. Russell, U. Oppermann

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

29

thyroid ultrastructure in the mature rat’s organism under influence of zometa

V. Koveshnikov, K. Fomina

Journal:

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

30

IPP/ApppI production and cellular drug uptake in synergistic action of doxorubicin and zoledronic acid

J. Kuokkanen, H. Mönkkönen, I. Holen ⁎, C.A. Evans ⁎, H.-K. Kotilainen, S. Auriola, J. Mönkkönen

Journal:

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

31

Ibandronate and Clodronate cause-dose and time- dependent apoptosis of human sarcoma cells in vitro

A.A. Kurth, U. Stumpf, S. Goettig, M. Schoenherr, R. Henschler

Journal:

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

32

Ibandronate improves osseointegration of implants in experimental osteoporosis

A.A. Kurth, C. Eberhardt, M. Schwarz, M. Steinacker, F. Bauss

Journal:

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

33

Refining the use of hydroxyapatite column chromatography to reveal differences in relative binding affinities of bisphosphonates

M.A. Lawson, Z. Xia, J.T. Triffitt, F.H. Ebetino, R.J. Phipps, R.G.G. Russell

Journal:

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

34

A cathepsin k inhibitor (alone or in combination with zoledronic acid) inhibits the progression of breast cancer bone metastases

C. Le Gall, J. Guglielmi, J. Gasser ⁎, J. Zimmermann ⁎, P. Clézardin

Journal:

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

35

Bone strength parameters under effect of glucocorticoids and zoledronic acid in rats

V. Luzin, L. Stklyanina

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

36

Mechanisms of bone cancer pain relief with bisphosphonates

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

37

Endochondral repair and development proceed normally during zoledronic acid treatment

M.M. McDonald, S.K. Dulai, C. Godfrey, T. Sztynda, D.G. Little

Journal:

Year:

2006

Language:

english

File:

PDF, 59 KB

english, 2006

38

Single dose zoledronic acid treatment is superior to continuous treatment in enhancing hard callus formation and strength without delayed remodelling

M.M. McDonald, S.K. Dulai, C. Godfrey, T. Sztynda, D.G. Little

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

39

Effects of Zoledronic acid and Paclitaxel on endothelial cells in vitro

M. Michailidou, H.L. Neville-Webbe, C.A. Evans, N.J. Brown, R.E. Coleman, I. Holen

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

40

Zoledronic acid induced IPP/ApppI accumulation in different cancer cell lines

H. Mönkkönen, I. Holen, A. Evans, M. Jauhiainen, S. Auriola, J. Mönkkönen

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

41

Crossover reaction of ibandronate elisa with zoledronate

B. Nauth, H. Faust, S. Zelger, R. Bergner

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

42

Zoledronic acid (ZOL) and letrozole (LET) induce synergistic levels of apoptosis in breast cancer cells

H.L. Neville-Webbe, D. Lefley, R.E. Coleman, I. Holen

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

43

Zoledronic acid induces osteosarcoma cell death by aif translocation and cell cycle arrest in S and G2/M phases

B. Ory, F. Blanchard, S. Couillaud, F. Gouin, F. Rédini, D. Heymann

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

44

Prevention of breast cancer cell adhesion to bone in vitro by bisphosphonates is mediated by their inhibitory effect on protein prenylation

Sweyn Garrioch, Anke J. Roelofs, F. Hal Ebetino, Michael J. Rogers

Journal:

Year:

2006

Language:

english

File:

PDF, 58 KB

english, 2006

45

The bisphosphonate–ester apomine does not act by inhibiting protein prenylation, but enhances the effects of lovastatin on myeloma cells

Anke J. Roelofs, Philippa A. Hulley, R. Graham, G. Russell, Claire M. Shipman

Journal:

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

46

Crystal structure of a dead-end complex with two isopentenyl diphosphate molecules sheds light on substrate recognition by human FPPS

J.-M. Rondeau, E. Bourgier, S. Lehmann, W. Jahnke

Journal:

Year:

2006

Language:

english

File:

PDF, 59 KB

english, 2006

47

Three structural snapshots of the FPPS catalytic cycle revealed by X-ray analyses of the human enzyme

J.-M. Rondeau, F. Bitsch, E. Bourgier, M. Geiser, R. Hemmig, M. Kroemer, S. Lehmann, P. Ramage, S. Rieffel, A. Strauss, J.R. Green ⁎, W. Jahnke

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

48

X-ray and 2D NMR analyses of the binding of nitrogen-containing bisphosphonate drugs to human FPPS

J.-M. Rondeau, F. Bitsch, E. Bourgier, M. Geiser, R. Hemmig, M. Kroemer, S. Lehmann, P. Ramage, S. Rieffel, A. Strauss, J.R. Green ⁎, W. Jahnke

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

49

Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen resistant prostate cancer cell line (PC3)

D. Santini, B. Vincenzi, M. Rosolowski, L. Altucci, M. Campioni, M. Loeffler, M. Caraglia, A. Baldi, G. Tonini

Journal:

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

50

Bisphosphonates potency in vivo and the compliance of the molecules with hydroxyapatite crystal unit structure

Journal:

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

51

Osteoclasts but not osteoblasts are affected by bisphosphonate bound to a calcified substrate

A. Schindeler, D.G. Little

Journal:

Year:

2006

Language:

english

File:

PDF, 68 KB

english, 2006

52

Nitrogen-containing bisphosphonates and alkylamines activate Vγ9Vδ2 T cells through a common mechanism involving inhibition of the mevalonate pathway

Keith Thompson, Hannu Mönkkönen ⁎, Jukka Mönkkönen ⁎, MichaelJ. Rogers

Journal:

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

53

Effects of chronic chlorobenzene administration on the femur in rats

Zs. Valkusz, Gy. Nagyéri, L. Gáspár, A. Juhász, A. Petri, B. Hegedűs, M. Gálfi

Journal:

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

54

Substitution of the R1 hydroxyl and C1 phosphate of risedronate produces differences in elution profiles on hydroxyapatite ceramic chromatographic columns

Z. Xia, M.A. Lawson, J.T. Triffitt, F.H. Ebetino, C.E. McKenna, M. Marma, B Kashimirov, R.G.G. Russell

Journal:

Year:

2006

Language:

english

File:

PDF, 75 KB

english, 2006

55

Novel vitamin B6 derivative of alendronate rapidly absorbed following oral administration

S. Zinnen, D. Sebesta, A. Karpeisky, A. Guzaev

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

56

Bishosphonates inhibit bone resorption in multicentric reticulohistiocytosis

I.E. Adamopoulos, B.P. Wordsworth, J.R. Edwards, D.J. Ferguson, N.A. Athanasou, R.G.G. Russell

Journal:

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

57

Zoledronic acid in adjuvant treatment of early breast cancer

B. Alonso, R. Alemán, L.M. Rguez, M. Llanos, E. Rguez, J. Cruz, J. Oramas, J.N. Batista

Journal:

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

58

Zoledronic acid in adjuvant treatment of early breast cancer after twelve months of the first cycle

R. Alemán, B. Alonso, L.M. Rguez, M. Llanos, E. Rguez, J. Cruz, J. Oramas, R. García, J.N. Batista

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

59

Prevention of post-bone marrow transplantation bone loss with zoledronate

A. Arabi, A. Bazarbachi, L. Dib, J. Makarem, H. Hatoum, A.R. Kanj, G. El-Hajj Fuleihan

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

60

Systemic and local zoledronate treatment of bilateral necrosis of caput femoris caused by SLE-a case report

J. Åstrand, U. Rydholm, M. Tägil

Journal:

Year:

2006

Language:

english

File:

PDF, 59 KB

english, 2006

61

Zoledronic acid versus ibandronate comparative evaluation in breast cancer patients with bone metastases: The NCRI zice trial

P.J. Barrett-Lee, N. Murray

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

62

Use of combined calcitonin and etidronate in bone mass loss with HIV-infection

A. Bazarra-Fernández

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

63

Cellular immunity in dialysis patients treated with ibandronate for 48 weeks

R. Bergner, B. Weiss, M. Hoffmann, D.M. Henrich, M. Uppenkamp

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

64

Pharmacokinetics of ibandronate in myeloma patients with renal insufficiancy

R. Bergner, D. Henrich, M. Hoffmann, M. Uppenkamp

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

65

Intravenous and oral ibandronate have better safety and tolerability profiles than zoledronic acid: Evidence from comparative phase III trials

B. Bergström, M. Lichinitser, J.J. Body

Journal:

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

66

Loading-dose ibandronate with maintenance dosing for the palliation of metastatic bone pain: The Bon-I-Pain and Bon-O-Pain trials

J.J. Body, J. Gralow, B. Bergström

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

67

Oral ibandronate and intravenous zoledronic acid in metastatic breast cancer patients: Comparative bone turnover marker and safety data

J.J. Body, M. Lichinitser, R.E. Coleman, B. Bergström

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

68

Ibandronate relieves pain and improves quality of life in breast cancer patients with metastatic bone disease: Phase III data

J.J. Body, B. Bergström

Journal:

Year:

2006

Language:

english

File:

PDF, 59 KB

english, 2006

69

For how long can a single infusion of zoledronic acid suppress bone resorption in patients with cancer treatment induced bone loss (CTIBL)?

J.E. Brown, J. Lester, S. Ellis, S. Gutcher, L. Turner, O. Purohit, R.E. Coleman

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

70

The AZURE trial – does adjuvant zoledronic acid reduce recurrence in patients with high-risk localised breast cancer?

R. Burkinshaw, H. Thorpe, S. Pollard, R. Bell, D. Dodwell, D. Cameron, R. Coleman

Journal:

Year:

2006

Language:

english

File:

PDF, 59 KB

english, 2006

71

Zoledronic acid reduces bone loss in men with prostate cancer receiving goserelin

R. Casey, W. Love, C. Mendoza, D. Reymond, M. Zarenda

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

72

A phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases despite standard bisphosphonate (BP) therapy

M. Clemons, G. Dranitsaris, W.S. Ooi, D.E.C. Cole

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

73

Effect of two-year discontinuation after five years of alendronate treatment in patients with postmenopausal osteoporosis

Miro Cokolic, Rok Hren

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

74

A randomized trial investigating different durations of adjuvant androgen deprivation with and without zoledronic acid in the treatment of localized carcinoma of the prostate

J. Denham, D. Joseph, D. Lamb, G. Duchesne, M. Copeman, K. Lynch

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

75

Intravenous (IV) bisphosphonates for osteopenic cancer survivor women: An alternative treatment

E. Rodríguez, M.C. Durán, L.M. Rodríguez, R. Ros, M.R. Alemán, M. Rodríguez-Gaspar, A.M. López, E. García-Valdecasas, F. Santolaria

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

76

The high prevalence of vitamin D insufficiency in postmenopausal women (PMW) with osteoporosis (OP) has not been significantly reduced after 12 months of treatment with Ca and vitamin D

A.E. Georgiadis, F. Papadopoulou, L. Tzianoumis, E. Georgiou

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

77

Renal safety of ibandronate in patients with relapsed and refractory multiple myeloma

A. Glasmacher, F. Hoffmann, K. Orlopp, M. von Lilienfeld-Toal, C. Hahn

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

78

S0307: A phase III trial of bisphosphonates as adjuvant therapy for primary breast cancer

J. Gralow, A. Paterson

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

79

Ibandronate in fracture healing – an overview

B. Habermann, C. Eberhardt, A.A. Kurth

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

80

Dose escalation of ibandronate in patients with multiple myeloma and end-stage renal disease – an open label study

D. Henrich, R. Bergner, M. Hoffmann, M. Uppenkamp

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

81

Rapid increase in levels of circulating osteoprotegerin (OPG) in patients with tumour-induced bone disease following zoledronic acid administration

I. Holen, D. Santini, B. Vincenzi, G. Tonini, R.A. Hannon

Journal:

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

82

Combined administration of darbepoetin and zoledronic acid in the treatment of refractory multiple myeloma (MM)

S. Improta, M. Caraglia, A. Lucania, M. Sagristani, M.R. Villa, A. Budillon, L. Mastrullo

Journal:

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

83

Phase III trial of oral ibandronate versus intravenous zoledronic acid in multiple myeloma: Study design

Journal:

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

84

BP-associated avascular necrosis (AN) of the jaws: Histological findings

S. Hoefert, W. Wierich, H. Eufinger, B. Krempien

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

85

Combination of irradiation and bisphosphonates in the therapy of bone metastases

R. Krempien, P.E. Huber, W. Harms, J. Debus, B. Krempien

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

86

Local treatment of giant cell tumors by a bone substitute material and a bisphosphonate

A.A. Kurth, B. Habermann, M. Salzmann, C. Eberhardt

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

87

Reduced bone pain by intensive bisphosphonate-therapy of new diagnosed bone metastases

A.A. Kurth, M. Pilz, U. Stumpf, A. Müller, C. Eberhardt

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

88

Pain reduction with oral and intravenous ibandronate treatment for metastatic bone disease of breast cancer

A.A. Kurth, J. Seraphin, F. Schütze, A. Nusch, I. Schäfer, H. Meden

Journal:

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

89

Descriptive analysis of bisphosphonates use in patients with cancer and bone metastasis

V. Launay-Vacher, S. Oudard, N. Janus, C. Le Tourneau, O. Rixe, X. Pourrat, J. Gligorov, J.F. Morere, P. Beuzeboc, G. Deray

Journal:

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

90

Renal insufficiency in cancer patients: Prevalence and implications on anticancer drugs management. Final results of the “IRMA” study

V. Launay-Vacher, S. Oudard, N. Janus, C. Le Tourneau, O. Rixe, X. Pourrat, J. Gligorov, J.F. Morere, P. Beuzeboc, G. Deray

Journal:

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

91

Bone resorption marker directed therapy for metastatic bone disease

J. Lester, J. Horsman, O.P. Purohit, J.E. Brown, R.E. Coleman

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

92

Characteristics and toxicity profile of patients receiving more than 2 years treatment with bisphosphonates for bone metastases from breast cancer

J.E. Lester, L. Penty, J.E. Brown, C. Radstone, O.P. Purohit, R.E. Coleman

Journal:

Year:

2006

Language:

english

File:

PDF, 60 KB

english, 2006

93

Ibandronate® in the adjuvant treatment of locally advanced prostate carcinoma (PCa)

T. Lindenmeir, F. Reiher, O. Rau, Th. Nelius, E.P. Allhoff

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

94

Bisphosphonate rescue in distraction osteogenesis: A case series

D.G. Little, K. Ward, P. Kiely, M.C. Bellemore, J. Briody, C.T. Cowell

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

95

Intravenous zoledronic acid effectively decreases serum calcium in primary hyperparathyroidism

W. Misiorowski, L. Papierska

Journal:

Year:

2006

Language:

english

File:

PDF, 86 KB

english, 2006

96

Why do patients with metastatic breast cancer (MBC) continue to have bone destruction despite bisphosphonate (BP) use? A pathologic review

W.S. Ooi, C. Gainford, H. Kahn, M. Kalina, S. Popovic, G. Singh, M. Clemons

Journal:

Year:

2006

Language:

english

File:

PDF, 77 KB

english, 2006

97

Short-term efficacy of alendronate in wheel-chair bound patients

W. Pluskiewicz, P. Adamczyk, P. Sawaryn, B. Drozdzowska

Journal:

Year:

2006

Language:

english

File:

PDF, 87 KB

english, 2006

98

Zoledronate prevents bone loss after stroke

K.E.S. Poole, E.A. Warburton, C. Rose, N. Loveridge, J. Reeve

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

99

Oral ibandronate versus intravenous zoledronic acid for breast cancer patients with skeletal complications: The swog trial

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

100

Bisphosphonates treatment for cancer induced osteopenia: effect on bone mineral density (BMD)

E. Rodríguez, R. Ros, L.M. Rodríguez, M.C. Duran, M.J. Sánchez, M.M. Alonso, A. Gómez, C.E. González-Reimers, A. Martínez, F. Santolaria

Journal:

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

101

Efficacy of zoledronic acid for the prevention of bone metastases in patients with non-small cell lung cancer

G. Scagliotti, C. Manegold, P. Kosmidis, A. Kirner

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

102

Tolerability of oral and intravenous ibandronate (BONDRONAT®) treatment of metastatic bone disease in breast cancer

I. Schäfer, J. Seraphin, F. Schütze, A. Nusch, H. Meden, A.A. Kurth

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

103

Impact of bisphosphonate therapy on the nature of spine metastases from breast cancer: An observational study

T. Skrinskas, M. Vanhuyse, W. Ooi, C. Whyne, M. Clemons

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

104

Efficacy of zoledronic acid for the reduction of bone marrow tumor cells in breast cancer patients receiving adjuvant therapy

E.-F. Solomayer, T. Fehm, G. Gebauer, W. Janni, H.-J. Lück, D. Wallwiener

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

105

Decreasing the catabolic response by a single bisphosphonate infusion shortens the healing time in hemicallotasis operations

M. Tägil, A. W-Dahl, J. Åstrand, D. Little, S. Toksvig-Larsen

Journal:

Year:

2006

Language:

english

File:

PDF, 60 KB

english, 2006

106

Bisphosphonate use for metastatic breast cancer –too much? too little? too late to start again?

M. Vanhuyse, M.C. Gainford, W. Ooi, G. Dranitsaris, M. Clemons

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

107

Jones fractures in patients with metastatic breast cancer (MBC)

C. Van Poznak, P. Boland, C. Morris, M. Dickler, C. Hudis, J. Healey

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

108

Treating bone metastases from solid tumors with a combination of ibandronate and radiotherapy: Clinical evaluation and radiological assessment

V. Vassiliou, C. Kalogeropoulou, Ch. Christopoulos, E.K. Solomou, D. Kardamakis

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

109

Experience with loading-dose ibandronate

R. von Moos, R. Cathomas, F. Egli, R. Inauen

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

110

The crosstalk between bone and cancer cells: Alterations of osteoblasts in gene expression and behavior are metastasis-type specific

K. Ackermann, W. Pyerin

Journal:

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

111

Evaluation of human periosteum derived cells for bone regeneration

H. Agata, I. Asahina, H. Kagami, M. Ueda

Journal:

Year:

2006

Language:

english

File:

PDF, 77 KB

english, 2006

112

Deletion of hypothalamic neuropeptide Y2-receptors in adult mice protects against continued ovariectomy-induced bone loss

S.J. Allison, P.A. Baldock, A. Sainsbury, R.F. Enriquez, M. During, J.A. Eisman, H. Herzog, E.M. Gardiner

Journal:

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

113

Central control of cortical bone homeostasis: Neuropeptide Y exerts a negative effect on cortical bone formation

P.A. Baldock, S. Allison, A. Sainsbury, R.F. Enriquez, E.M. Gardiner, H. Herzog, J.A. Eisman

Journal:

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

114

A novel LRP5 mutation in a patient with increased bone mass results in reduced DKK1-inhibition

W. Balemans, J.P. Devogelaer, E. Cleiren, W. Van Hul

Journal:

Year:

2006

Language:

english

File:

PDF, 67 KB

english, 2006

115

Teriparatide and HRT against osteoporosis of woman

A. Bazarra-Fernández

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

116

Decreased bone formation with ageing: Consequence of an imbalance between BMP agonists and antagonists?

D. Egrise, A. Schoutens, S. Goldman, P. Bergmann

Journal:

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

117

Arrestin-regulated genes in osteoblasts exposed to intermittent or continuous PTH

E.N. Bianchi, D.D. Pierroz, D. Manen, R. Rizzoli, S.L. Ferrari

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

118

Wnt signaling in osteoblast differentiation and bone formation

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

119

Uptake of bone-related matrix proteins into implanted deproteinized bovine bone mineral

D.D. Bosshardt, B. Wallkamm, R.K Schenk, D. Buser, N.P. Lang

Journal:

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

120

FRA-2 is a novel regulator of bone development affecting osteoclasts, osteoblasts and chondrocytes

Aline Bozec, Astrid Hoebertz, Arndt F. Schilling, Florian Karreth, Harald Scheuch, Matthias Priemel, Michael Amling, Robert Eferl, Erwin F. Wagner

Journal:

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

121

Resistin, an adipocytokine, stimulates osteoblast and osteoclast proliferation

J. Cornish, K.E. Callon, M. Watson, J.-m. Lin, I.R. Reid

Journal:

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

122

BIM is a novel regulator of glucocorticoid-induced apoptosis in osteoblasts

B. Espina, R.G.G. Russell, P. Hulley

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

123

Dynamic measurement system of interfragmentary movements in patients treated with ilizarov external fixation

J.-H. Kuiper, F. Li, S.A. Khan, C.E. Evans

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

124

Low dose PTH, insufficient to induce cyclic AMP or C-fos, stimulates an anabolic gene response in human osteoblasts in vitro

K.A. Buckley, J.P. Dillon, B.Y.Y. Chan, A. Gartland, W.D. Fraser, J.A. Gallagher

Journal:

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

125

Release of ATP from human osteoblastic cell lines and primary osteoblasts occurs via exocytosis

B.K. Mwaura, M.J. Hayton, J.P. Dillon, H.E. Burrell, J.A. Gallagher, A. Gartland

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

126

Hyperhomocysteinemia increases bone fragility and reduces osteoblast activity in adult wistar rats

M. Herrmann, L. Claes, B. Wildemann, S. Klohs, S. Schorlemmer, O. Taban, W. Herrmann

Journal:

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

127

Effects of mevastatin on grafted bone in MRL/MpJ mice

M. Sugazaki, H. Hirotani, S. Mori, S. Takeyama, S. Echigo, H. Shinoda

Journal:

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

128

Elevated expression of FGF23 in bone in an in vivo murine model of primary hyperparathyroidism

Y. Imanishi, T. Kawata, K. Kobayashi, T. Miki, A. Arnold, M. Inaba, Y. Nishizawa

Journal:

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

129

Changes of bone quality of cortical bone formed under alendronate treatment were detected by microbeam X-ray diffraction analysis

M. Kashii, J. Hashimoto, T. Nakano, Y. Umakoshi, H. Yoshikawa

Journal:

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

130

21 Bone remodeling and the roles of nuclear receptor

S. Kato, T. Nakamura, T. Sato, Y. Yamamoto

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

131

Higher bone mineral density and bone mineral content in endemic fluorosis: Human study

Arjun L. Khandare, G. Shanker Rao, N. Balakrishna

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

132

Selective targeting of DR5 circumvents resistance of MG-63 osteosarcoma to trail-induced apoptosis

R.M. Locklin, E. Federici, B. Espina, P. Hulley, R.G.G. Russell, C.M. Shipman

Journal:

Year:

2006

Language:

english

File:

PDF, 60 KB

english, 2006

133

Concordance rate of osteoporosis self-assessment tool for Asians and dual energy X-ray absorptiometry in diagnosis of osteoporosis

Chunyan Lu, Yunhua Cai, Decai Chen, Songquan Wei

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

134

Effect of serum containing chinese herb of strengthening kidney on proliferation and differentiation of human osteoblast

Z.G. Luo, Y. Zhao, A.T. Wang, W.S. Yu, P. Hu, B. Feng

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

135

Experimental study of biological mechanism in treating of fracture by chinese herbal medicine

Z.G. Luo, W.S. Yu, A.T. Wang, Y. Zhao, G. Huang, B. Feng

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

136

Postnatal growth and formation of the mandible in intact rat

V. Luzin, A. Noskova, Yu. Koptseva, O. Andrieieva

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

137

Do adenosine and glutamate-mediated signalling pathways interact in osteoblasts and osteocytes?

D.J. Mason, B.A.J. Evans, A. Burleigh, K. Duggan, O. Lorraine, A. Pexa, A. Deussen, J. Ham

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

138

Three dimensional reconstruction of haversian canals using X-ray micro-computed tomography

S. Mohsin, F.J. O’Brien, T.C. Lee, M. Gehl, W. Gowin

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

139

Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation

K. Nakagawa, Y. Ohta, Y. Imai, C. Nomura, K. Takaoka

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

140

Enhancement of BMP signaling by cyclic AMP: Its role and mechanism

Y. Ohta, K. Nakagawa, Y. Imai, C. Nomura, T. Katagiri, T. Koike, K. Takaoka

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

141

Age-specific characteristics of axial skeleton mineralization in children

L.A. Scheplyagina, T.Y. Moisseyeva, I.V. Kruglova

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

142

BMP-2 treatment produces an attenuated response in a mouse model of type 1 neurofibromatosis

A. Schindeler, M. Ramachandran, D.G. Little

Journal:

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

143

Increased cortical bone in betacellulin transgenic mice

M.R. Schneider, M. Dahlhoff, R.G. Erben, E. Wolf

Journal:

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

144

Surgical induction of temporomandibular ankylosis: An animal model

X.J. Shi, L.K. Cheung

Journal:

Year:

2006

Language:

english

File:

PDF, 58 KB

english, 2006

145

Protective effect of vitamin D3 on methylprednisolone acetate (MPA) induced loss of bone metabolism markers and bone mineral density in the lumbar spine of rat

A. Sobhani, F. Moradi, P. Pasbakhsh, I.R. Kashani

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

146

Inhibition of FIAT (factor inhibiting ATF4-mediated transcription) by rna knockdown upregulates osteocalcin transcription in osteoblastic cells

V.W.C. Yu, R. St-Arnaud

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

147

Three-dimensional osteoblast cultures on synthetic hydroxy-apatite support: Molecular characterization and vascularization study after implant on chick allantochorial membrane

L. Mancini, R. Tamma, M.P. Settanni, C. Camerino, N. Patano, A. Zallone

Journal:

Year:

2006

Language:

english

File:

PDF, 58 KB

english, 2006

148

Klotho is an essential molecule responsible for tissue specific FGF23 signaling

I. Urakawa, Y. Yamazaki, T. Shimada, K. Iijima, H. Hasegawa, T. Fujita, S. Fukumoto, T. Yamashita

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

149

The small molecule nmp is an enhancer of bone regeneration

F.E. Weber, B. San Miguel, M. Ehrbar, C. Ghayor, R. Jung, R. Zwahlen

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

150

Expression of collagen VI in bone and osteosarcoma cell lines reveals its role in the development of bone matrix

P.J.M. Wilson, S.C. Wagstaff, B.W. Wlodarski, J.P. Dillon, W.D. Fraser, J.A. Gallagher

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

151

Estrogen receptor alpha expression in osteocytes has a regional distribution regulated preferentially by estrogen but not by mechanical strain

G. Zaman, H.L. Jessop, M. Muzylak, R. Souza, A.A. Pitsillides, J.S. Price, L.E. Lanyon

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

152

Effect of nicotine on bone healing in mandibular distraction osteogenesis

L.W. Zheng, L. Ma, L.K. Cheung

Journal:

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

153

Elevated serum activity of TRACP5B in osteosarcoma patients (OS) is associated with an aggressive phenotype and with OS induced osteoclast activity

S. Avnet, A. Pellacani, A. Longhi, F. Perut, D. Granchi, A. Giunti, N. Baldini

Journal:

Year:

2006

Language:

english

File:

PDF, 65 KB

english, 2006

154

RANKL negatively regulates the binding of a 125 KDa transcriptional repressor within the mouse Tcirg1 gene promoter during osteoclastogenesis

G.E. Beranger, D. Momier, D. Quincey, J.-C. Scimeca, G.F. Carle

Journal:

Year:

2006

Language:

english

File:

PDF, 74 KB

english, 2006

155

Role of CCN1 protein in osteoclast-mediated bone resorption after low-level cadmium

M.H. Bhattacharyya, M. Valdez, K. Tormos, L. Agha, L. Smith, A.K. Wilson

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

156

Oxytocin: An estrogen-controlled autocrine-paracrine modulator of osteoclastogenesis and bone resorption

G. Colaianni, R. Tamma, A. Di Benedetto, N. Patano, C. Camerino, S. Li, M. Zaidi, A. Zallone

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

157

Effects of increasing fruit and vegetable intake on bone turnover in postmenopausal osteopenic women

S. Ebrahimof, A. Hossein-Nezhad, A. Hoshyarrad, M. Rahmani, N. Valayi, B. Larijani, S.M. Kimiagar

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

158

sRANKL, OPG and rank are modulated by pressure and age of donor in macrophages and osteoblasts

C.E. Evans, S. Mylchreest, J.G. Andrew

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

159

Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with Receptor Activator of Nuclear Factor kB Ligand (RANKL) and RANK

S. Théoleyre, S. Kwan Tat, P. Vusio, F. Blanchard, J. Gallagher, S. Ricard-Blum, Y. Fortun, M. Padrines, F. Rédini, D. Heymann

Journal:

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

160

Non-viral osteoprotegerin gene transfer inhibits the tumor progression and prolongs survival in a mouse experimental model of osteosarcoma

F. Lamoureux, P. Richard, Y. Wittrant, V. Trichet, B. Pitard, D. Heymann, F. Rédini

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

161

The effects of tumor necrosis factor-α on osteoclast formation depend on the haematopoietic precursors

Jeannette Portenier, Silvia Dolder, Antoinette Wetterwald, Willy Hofstetter

Journal:

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

162

Association of c-SRC and adhesion and degranulation-promoting adaptor protein (ADAP) in osteoclastogenesis in vitro

S. Koga, K. Yogo, K. Yoshikawa, N.I. Kitagawa, T. Takeya

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

163

the influence of vitamin D supplementation on OPG/RANKL/RANK system in postmenopausal women: the six month clinical study

Z. Krivošíková, V. Spustová, K. Štefíková, R. Dzúrik

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

164

Influence of electro-acupuncture on bone mineral density, bone strength and ultrastructure in ovariectomized rats

Z.G. Luo, A.T. Wang, W.S. Yu, Y. Zhao, P. Hu, B. Feng, G. Huang

Journal:

Year:

2006

Language:

english

File:

PDF, 96 KB

english, 2006

165

ADAMs in the formation of foreign body giant cells and osteoclasts

M.A. Guofeng, M. Ainola, M. Liljeström, M. Hukkanen, J. Salo, Y.T. Konttinen

Journal:

Year:

2006

Language:

english

File:

PDF, 93 KB

english, 2006

166

Functional analysis of HB-EGF during osteoclastogenesis

T. Nakamura, A. Yoshimoto, N.I. Kitagawa, K. Yogo, T. Takeya

Journal:

Year:

2006

Language:

english

File:

PDF, 48 KB

english, 2006

167

Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast

K. Oshima, A. Nampei, M. Matsuda, M. Iwaki, A. Fukuhara, J. Hashimoto, H. Yoshikawa, I. Shimomura

Journal:

Year:

2006

Language:

english

File:

PDF, 48 KB

english, 2006

168

Immunogenic properties of renal cell carcinoma favour osteoclast recruitment in bone metastases

F. Perut, E. Cenni, R.E. Unger, C.J. Kirkpatrick, A. Giunti, N. Baldini

Journal:

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

169

Cardiotrophin-1 regulates osteoclast and osteoblast function in a manner distinct from other gp130 cytokines

N.A. Sims, E.C. Walker, J.M.W. Quinn, E.A. Allen, H. Saleh, T.J. Martin

Journal:

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

170

Effect of olpadronate on post-tooth extraction healing in rats. A cronodinamic study

M.G. Sivak, P.M. Mandalunis, M.B. Guglielmotti

Journal:

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

171

A novel bisphosphonate, TRK-530, for periodontitis

S. Takeyama, M. Ito, H. Shinoda

Journal:

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

172

Alkylamines prevent osteoclast formation and activity by inhibiting the mevalonate pathway

K. Thompson, T.M. Kikuvi, M.J. Rogers

Journal:

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

173

Osteoprotegerin (OPG) expression in breast tumours and bone metastases

C. Van Poznak, P. Ottewell, S. Cross, C. Hudis, R.E. Coleman, I. Holen

Journal:

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

174

Colony-stimulating factor-1 does not induce irreversible commitment of marrow precursors to the macrophage lineage

Antoinette Wetterwald, Jeannette Portenier, Willy Hofstetter

Journal:

Year:

2006

Language:

english

File:

PDF, 48 KB

english, 2006

175

67 Storage conditions are crucial to maintain phenotypes in osteochondral grafts

J.D. Bastian, R.J. Egli, R. Ganz, W. Hofstetter, M. Leunig

Journal:

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

176

68 Glucosamine sulfate inhibits IL-1-stimulated chondrocyte aggrecanase expression, and is effective in a rat model of osteoarthritis

R. Chiusaroli, T. Piepoli, F. Colombo, L. Catapano, L.C. Rovati, G. Caselli

Journal:

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

177

69 Expression of Runx2 transcription factor in sperm

J.H. Jeong, J.S. Jin, A.J. van Wijnen ⁎, J.L. Stein ⁎, J.B. Lian ⁎, G.S. Stein ⁎, J.-Y. Choi

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

178

70 Human embryonic stem cell-derived connective tissue progenitors for tissue engineering

S. Cohen, L. Leshansky, E. Zussman, J. Itskovitz-Eldor

Journal:

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

179

71 Expansion of bovine chondrocytes in hypoxic conditions promotes the formation of cartilage-like matrix in high density micromass cultures

R.J. Egli, R. Ganz, W. Hofstetter, M. Leunig

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

180

72 The synergistic effect of extracellular nucleotides and EGF on C-Fos expression in two breast cancer cell lines

A. Gartland, R.A. Hipskind, W.D. Fraser, J.A. Gallagher

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

181

72a Inorganic phosphate stimulates matrix GLA protein expression in growth plate chondrocytes through the ERK signaling pathway

M. Julien, D. Magne, A. Clochard, M. Rolli-Derkinderen, O. Chassande, C. Cario-Toumaniantz, Y. Cherel, P. Weiss, J. Guicheux

Journal:

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

182

73 Ionotropic glutamate receptors are functional in human fibroblast-like synoviocytes and modulate IL-6 and MMP-2 expression

S.J. Flood, R. Parri, A. Williams, V.C. Duance, D.J. Mason

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

183

74 Identification of a CTCF-binding site between the Rxrb and the Col11a2 genes, and its functions

J. Murai, H. Yoshikawa, N. Tsumaki

Journal:

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

184

75 Recombinant human cartilage-derived retinoic acid sensitive protein (CD-RAP)—a novel treatment option for osteochondral defects

S.D. Pippig, K. Hellerbrand, C. Dony

Journal:

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

185

76 Carbon dioxide rich water bathing increases local vegf secretion and CD34+CD33+ endothelial progenitor cells in ischemic lower limbs of DM and ASO patients

K. Saito, M. Nonomura

Journal:

Year:

2006

Language:

english

File:

PDF, 48 KB

english, 2006

186

77 Catch-up growth in experimental chronic renal failure (CRF). Effect of growth hormone (GH)

I. Molinos, F Santos, E. Carbajo, E. García, J. Rodríguez, H. Gil, O. Alvarez-Garcia, V. Loredo, L. Mallada

Journal:

Year:

2006

Language:

english

File:

PDF, 48 KB

english, 2006

187

Comparison of renal impairment in multiple myeloma patients treated with zoledronic acid or ibandronate: A retrospective review

L. Antràs, M. Smith, M. Neary, J. Green, N. Wintfeld, M.S. Duh

Journal:

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

188

Risedronate demonstrates fracture efficacy in postmenopausal women whether there is a BMD gain or loss during treatment

N. Watts, S. Magowan, J. Brown, I. Barton, S. Boonen, P. Miller

Journal:

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

189

Editorial Board

Journal:

Year:

2006

Language:

english

File:

PDF, 41 KB

english, 2006

190

Frontiers of Skeletal Biology

Journal:

Year:

2006

Language:

english

File:

PDF, 194 KB

english, 2006

191

Program: What is New in Bisphosphonates?

Journal:

Year:

2006

Language:

english

File:

PDF, 184 KB

english, 2006